In Vivo "MRI Phenotyping" Reveals Changes in Extracellular Matrix Transport and Vascularization That Mediate VEGF-Driven Increase in Breast Cancer Metastasis

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Pathak, Arvind P ^a   McNutt, Stephen ^a   Shah, Tariq ^a   Wildes, Flonne ^a   Raman, Venu ^a   Bhujwalla, Zaver M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; VALIDATION STUDY; VASCULARIZATION; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; MCF 7 CELL LINE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; TUMOR INVASION; TUMOR MICROENVIRONMENT;

ANIMALS; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; EXTRACELLULAR MATRIX; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MCF-7 CELLS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84877079040     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063146     Document Type: Article

References (52)

1. Boudreau N, Myers C, (2003) Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment. Breast Cancer Res 5: 140-146.
2. Eccles S, Paon L, Sleeman J, (2007) Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms. Clin Exp Metastasis 24: 619-636.
3. Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, et al. (1999) Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 5: 1041-1056.
4. Tlsty TD, Coussens LM, (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol 1: 119-150.
5. Shields JD, Fleury ME, Yong C, Tomei AA, Randolph GJ, et al. (2007) Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 11: 526-538.
6. Liotta LA, Kohn EC, (2001) The microenvironment of the tumour-host interface. Nature 411: 375-379.
7. Pathak AP, Artemov D, Neeman M, Bhujwalla ZM, (2006) Lymph node metastasis in breast cancer xenografts is associated with increased regions of extravascular drain, lymphatic vessel area, and invasive phenotype. Cancer Res 66: 5151-5158.
8. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, et al. (2002) Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196: 1497-1506.
9. Ferrara N, Gerber HP, LeCouter J, (2003) The biology of VEGF and its receptors. Nat Med 9: 669-676.
10. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, et al. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985.
11. Weidner N, Semple JP, Welch WR, Folkman J, (1991) Tumor Angiogenesis and Metastasis- Correlation in Invasive Breast Carcinoma. New Eng J Med 324: 1-8.
12. Gasparini G, (2000) Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 5Suppl 1: 37-44.
13. Manders P, Beex LV, Tjan-Heijnen VC, Geurts-Moespot J, Van Tienoven TH, et al. (2002) The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy. Br J Cancer 87: 772-778.
14. Mercurio AM, Lipscomb EA, Bachelder RE, (2005) Non-angiogenic functions of VEGF in breast cancer. J Mammary Gland Biol Neoplasia 10: 283-290.
15. Dafni H, Israely T, Bhujwalla ZM, Benjamin LE, Neeman M, (2002) Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin. Cancer Res 62: 6731-6739.
16. Miralem T, Steinberg R, Price D, Avraham H, (2001) VEGF(165) requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells. Oncogene 20: 5511-5524.
17. Pathak AP, Artemov D, Ward BD, Jackson DG, Neeman M, et al. (2005) Characterizing extravascular fluid transport of macromolecules in the tumor interstitium by magnetic resonance imaging. Cancer Res 65: 1425-1432.
18. Shafie SM, Liotta LA, (1980) Formation of metastasis by human breast carcinoma cells (MCF-7) in nude mice. Cancer Lett 11: 81-87.
19. Kurebayashi J, McLeskey SW, Johnson MD, Lippman ME, Dickson RB, et al. (1993) Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ. Cancer Res 53: 2178-2187.
20. Zhang HT, Craft P, Scott PA, Ziche M, Weich HA, et al. (1995) Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 87: 213-219.
21. Weis SM, Cheresh DA, (2005) Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437: 497-504.
22. Bhujwalla ZM, Artemov D, Natarajan K, Ackerstaff E, Solaiyappan M, (2001) Vascular Differences Detected by MRI for Metastatic Versus Nonmetastatic Breast and Prostate Cancer Xenografts. Neoplasia 3: 143-153.
23. Monsky WL, Fukumura D, Gohongi T, Ancukiewcz M, Weich HA, et al. (1999) Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res 59: 4129-4135.
24. Donahue KM, Weisskoff RM, Burstein D, (1997) Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 7: 102-110.
25. Cao M, Liang Y, Shen C, Miller KD, Stantz KM, (2009) Developing DCE-CT to quantify intra-tumor heterogeneity in breast tumors with differing angiogenic phenotype. IEEE Trans Med Imaging 28: 861-871.
26. Balduyck M, Zerimech F, Gouyer V, Lemaire R, Hemon B, et al. (2000) Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin Exp Metastasis 18: 171-178.
27. Ratel D, Mihoubi S, Beaulieu E, Durocher Y, Rivard GE, et al. (2007) VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases. Thromb Res 121: 203-212.
28. Pepper MS, Ferrara N, Orci L, Montesano R, (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181: 902-906.
29. Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML, (2005) Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 169: 681-691.
30. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, et al. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2: 737-744.
31. Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, et al. (2004) Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 94: 664-670.
32. Van den Eynden GG, Van der Auwera I, Van Laere SJ, Trinh XB, Colpaert CG, et al. (2007) Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer. J Pathol 213: 56-64.
33. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, et al. (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201: 1089-1099.
34. Mohammed RA, Green A, El-Shikh S, Paish EC, Ellis IO, et al. (2007) Prognostic significance of vascular endothelial cell growth factors-A,-C and-D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 96: 1092-1100.
35. Wong SY, Hynes RO, (2007) Tumor-lymphatic interactions in an activated stromal microenvironment. J Cell Biochem 101: 840-850.
36. Ji RC, (2006) Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev 25: 677-694.
37. Haessler U, Teo JC, Foretay D, Renaud P, Swartz MA, (2012) Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber. Integr Biol (Camb) 4: 401-409.
38. Swartz MA, Lund AW, (2012) Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat Rev Cancer 12: 210-219.
39. Dafni H, Landsman L, Schechter B, Kohen F, Neeman M, (2002) MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor. NMR Biomed 15: 120-131.
40. Monsky WL, Mouta Carreira C, Tsuzuki Y, Gohongi T, Fukumura D, et al. (2002) Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Clin Cancer Res 8: 1008-1013.
41. Chung J, Bachelder RE, Lipscomb EA, Shaw LM, Mercurio AM, (2002) Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J Cell Biol 158: 165-174.
42. Bachelder RE, Wendt MA, Mercurio AM, (2002) Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62: 7203-7206.
43. Price DJ, Miralem T, Jiang S, Steinberg R, Avraham H, (2001) Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ 12: 129-135.
44. Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, et al. (2003) Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res 63: 5230-5233.
45. Robinson BD, Sica GL, Liu YF, Rohan TE, Gertler FB, et al. (2009) Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res 15: 2433-2441.
46. Ackerstaff E, Gimi B, Artemov D, Bhujwalla ZM, (2007) Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell line. Neoplasia 9: 222-235.
47. Ogan MD, (1988) Albumin labeled with Gd-DTPA: an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 23: 961.
48. Aukland K, Nicolaysen G, (1981) Interstitial fluid volume: local regulatory mechanisms. Physiol Rev 61: 556-643.
49. Butler TP, Grantham FH, Gullino PM, (1975) Bulk transfer of fluid in the interstitial compartment of mammary tumors. Cancer Res 35: 3084-3088.
50. Cox RW, (1996) AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages. Comptr Biomed Res 29: 162-173.
51. Banerji S, Ni J, Wang SX, Clasper S, Su J, et al. (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144: 789-801.
52. Russ JC, Dehoff RT (1999) Classical Stereological Measures. Practical Stereology. New York: Plenum Press. 39-70.